Cargando…
Plasma YKL-40: A BMI-Independent Marker of Type 2 Diabetes
OBJECTIVE—YKL-40 is produced by macrophages, and plasma YKL-40 is elevated in patients with diseases characterized by inflammation. In the present study, YKL-40 was examined in relation to obesity, inflammation, and type 2 diabetes. RESEARCH DESIGN AND METHODS—Plasma YKL-40 and adipose tissue YKL-40...
Autores principales: | Nielsen, Anders R., Erikstrup, Christian, Johansen, Julia S., Fischer, Christian P., Plomgaard, Peter, Krogh-Madsen, Rikke, Taudorf, Sarah, Lindegaard, Birgitte, Pedersen, Bente K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570404/ https://www.ncbi.nlm.nih.gov/pubmed/18650368 http://dx.doi.org/10.2337/db08-0182 |
Ejemplares similares
-
Calprotectin — A Novel Marker of Obesity
por: Mortensen, Ole Hartvig, et al.
Publicado: (2009) -
Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease
por: Holmgaard, Dennis B, et al.
Publicado: (2013) -
Low fitness is associated with abdominal adiposity and low-grade inflammation independent of BMI
por: Wedell-Neergaard, Anne-Sophie, et al.
Publicado: (2018) -
Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999) -
Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)